The FACT-B is appropriate for use in oncology clinical trials, as well as in clinical practice. It demonstrates ease of administration, brevity, reliability, validity, and sensitivity to change.
No takes yet. Share an insight, caveat, or question.
Brady et al. (1997) studied this question.